Is Bitcoin’s Fall Over? Top Crypto Analyst Says ‘Altcoins Are Going To Take Over Until…’

Popular crypto analyst Michaël van de Poppe has projected a prolonged recovery period for Bitcoin (CRYPTO: BTC) while anticipating a surge in altcoin performance.

Popular crypto analyst Michaël van de Poppe has projected a prolonged recovery period for Bitcoin (CRYPTO: BTC) while anticipating a surge in altcoin performance.

What Happened: Van de Poppe, in a recent post on social media platform X, suggested that Bitcoin’s recovery might be a lengthy process.

He wrote, “It’s going to take a while for #Bitcoin. However, most of the downside is done. There might be another 5-10% correction, but from here, altcoins are going to take over until Bitcoin breaks the all-time high.”

See Also: Are Dogecoin And Shiba Inu Due A Bounce? This Trader Sees ‘Bull Flag’ Forming For One Coin

Why It Matters: This forecast comes at a time when the cryptocurrency market is experiencing significant turbulence. Just a day before, another analyst, Ali Martinez, had suggested a potential 99% surge in Bitcoin’s value, based on historical data, and advised investors to buy the dip.

Despite the recent market volatility, Bitcoin has continued to outperform other asset classes, as highlighted by economist Mohamed El-Erian.

However, not all analysts are as optimistic about Bitcoin’s future. Renowned economist and gold bull Peter Schiff recently identified a bearish technical pattern in Bitcoin’s chart, suggesting that the ongoing selloff could continue.

Price Action: Bitcoin is currently trading at $57,726, marking a 0.93% decline over the last 24 hours. Nonetheless, it has surged by 30.69% since the beginning of the year, according to the data from Benzinga Pro.

Read Next: Shiba Inu’s Burn Rate Soars, Cathie Wood Believes Ethereum Could Catch Up To Bitcoin And More: Top Crypto Updates This Week

Image Via Shutterstock


Engineered by Benzinga Neuro, Edited by Kaustubh Bagalkote


The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.


Total
0
Shares
Related Posts
Read More

Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. Dermata Therapeutics shares jumped 57.3% to $0.9601 in pre-market trading.

AIMD